PETA India Calls For Their Immediate Closure to Help Prevent Disease
A total of 12 institutes have been asked by the ICMR to fast track clinical trials of the vaccine as it is being considered the topmost priority projects which are being monitored by the government.
India's approval for Zydus comes days after privately held Bharat Biotech got a similar green light for human studies for its vaccine candidate.
Shares of Moderna were trading at $57.61. The stock has risen more than 200% so far in 2020.
Here is the latest update on COVID-19 vaccines from different pharmaceutical companies
DCGI permits human clinical trials for COVID-19 vaccine of Zydus Cadila
The potential treatment is the fourth early-stage COVID-19 drug to show promise in human testing, along with projects involving Moderna, CanSino Biologics and Inovio Pharmaceuticals.
The most legit answer to the question asked is, the people of the country where the vaccine is developed are the initial and the foremost one to avail it
Denial to accept the diagnosis, treating symptoms partially can mask this condition for some time and hence by the time the actual consultation happens, the diseases could be in a severe or advanced stage.
Newborn babies are often very susceptible to a variety of conditions such as low blood oxygen, infections, low birth weight and low blood hemoglobin
Your e-mail iformation will not be shared with anyone else. And it will be used only to send out our latest news.